Vanguard Group Inc Royalty Pharma PLC Transaction History
Vanguard Group Inc
- $5.97 Trillion
- Q2 2025
A detailed history of Vanguard Group Inc transactions in Royalty Pharma PLC stock. As of the latest transaction made, Vanguard Group Inc holds 36,377,678 shares of RPRX stock, worth $1.3 Billion. This represents 0.02% of its overall portfolio holdings.
Number of Shares
36,377,678
Previous 36,677,448
0.82%
Holding current value
$1.3 Billion
Previous $1.14 Billion
14.79%
% of portfolio
0.02%
Previous 0.02%
Shares
17 transactions
Others Institutions Holding RPRX
# of Institutions
497Shares Held
306MCall Options Held
1.99MPut Options Held
384K-
Morgan Stanley New York, NY46.6MShares$1.67 Billion0.11% of portfolio
-
Black Rock Inc. New York, NY23MShares$825 Million0.01% of portfolio
-
Capital International Investors Los Angeles, CA21.9MShares$785 Million0.14% of portfolio
-
Baillie Gifford & CO18MShares$646 Million0.51% of portfolio
-
Swedbank Ab Stockholm, V712.2MShares$436 Million0.51% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $15.7B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...